Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Lance B's : Its A Beautiful Thing -- Ignore unavailable to you. Want to Upgrade?

To: LANCE B who wrote (3827)	2/10/2000 10:32:00 AM
From: Eric Fader	Respond to of 4792

Message 12816188 Up 23/32 today. New telecom product rollout is imminent, I'm told.

To: LANCE B who wrote (3827)	2/10/2000 11:04:00 AM
From: TGO	Read Replies (1) \| Respond to of 4792

Lance--I feel the MM "tiny" little fingers slipping.....USCM.will run....... TGO

To: LANCE B who wrote (3827)	2/10/2000 2:01:00 PM
From: AKAPAK	Respond to of 4792

Just another unusual volume stock: NEOP Don't have any clues but keep playing each time this happens <VBG> Best Trading

To: LANCE B who wrote (3827)	2/11/2000 9:21:00 PM
From: wayne	Respond to of 4792

lance what is the read on this? you still holding after the big E? February 11, 2000 18:07 National Boston Medical Issues Statement to Shareholders Jump to first matched term Company Announces Protective Measures on Shareholders Behalf TAUNTON, Mass., Feb. 11 /PRNewswire/ -- National Boston Medical, Inc. (OTC Bulletin Board: NMBXE) announced today that it is finalizing plans to ensure the Company's future in the public stock markets. Because of comments on its Form 10-SB, the filing has been delayed as a result of accounting issues that arose before the current management gained control of the Company. These issues appear to deprive the Company of its ability to comply with SEC financial reporting requirements. As a result of not clearing comments, National Boston Medical, Inc. received the "E" at the end of their stock symbol in accordance with recent filing guidelines issued by the OTC: BB. "While the Company and its independent auditors have been involved in continuing discussions with the SEC, we have been simultaneously reviewing alternate courses of action. We believe that we now have a plan in place that will benefit the shareholders," said Daniel Hoyng, Chairman and CEO of National Boston Medical, Inc. National Boston Medical, Inc. currently consists of two distinct operating subsidiaries. Infotopia focuses on producing infomercials and marketing unique products to the public. Bontempi is NBM's medical supply division, devoted to supplying high-end surgical and dental instruments to dentists, doctors and hospitals worldwide. Mr. Hoyng stated, "Our discussion of future plans for National Boston Medical, Inc. have included the consideration of the separation into two distinct operating companies. By accelerating this process, we have a unique opportunity to turn our current situation into something very positive. We plan to spin each subsidiary into its own fully reporting, publicly trading entity. Under our current plans, each entity will have it's own share structure, Board of Directors and management teams. Final plans are being formulated at this time by the Company's management, attorneys and accountants to implement this plan. The primary objective is to address the best interest of the shareholders, which management believes is to keep Infotopia and Bontempi in fully separate reporting and trading companies. To provide the Company time to implement this plan, the Company filed a Form 15 with the SEC today to suspend its reporting status. It is anticipated that the revised structure would provide for two reporting entities each quoted on the appropriate national reporting system. Management is committed to implementation of this plan as quickly as possible and throughout the process will provide shareholder updates. The Company will apply for continued quotation on the "pink sheets" once its eligibility on the OTC: BB ceases. National Boston Medical, Inc. operates two divisions: the Bontempi Instruments Plus and Infotopia. Bontempi Instruments Plus designs, manufactures and distributes a variety of medical, health and hygienic products, including the Bontempi line of medical, dental and veterinary surgical instruments. Infotopia specializes in Direct Response infomercials marketing a growing line of products, including the Backstroke(R) Back Massager, Cactus Jack's line of One Shot Products and Dean Torabene's health, fitness and lifestyle enhancing products. The statements in this release regarding future results of operations are forward-looking statements within the meaning of the Private Securities Litigation Act of 1995. Although the Company believes the expectation reflected in such forward-looking statements are based on reliable assumptions, it can give no assurance that its expectations will be obtained. The Company disclaims any intent or obligation to update these forward- looking statements. SOURCE National Boston Medical, Inc. /CONTACT: Mark Cohen or Doug Dubrow of The Pinnacle Group, 516-773-2477/ /Web site: nbmedical.com (NBMXE)

To: LANCE B who wrote (3827)	2/13/2000 9:55:00 AM
From: StocksDATsoar	Read Replies (1) \| Respond to of 4792

MPSS From profitpicks.com Recently developed an internet entertainment content provider named MPEG Super Site to build a major internet presence, rumored to be making several more ventures into the internet, including an online music store that will open in the coming weeks, rumored to have many partnerships in the works, including a tremendous partnership with DIS to webcast ABC/DIS movies, sporting events and concerts, rumored to be closing several major production deals in the next few weeks, rumored to be possibly spinning off its MPEG Super Site division as a NASDAQ IPO in the future, aggressive company, small float of only 3 million shares, rumors state that there are enormous short positions that need to be covered in an uptrend, strong, though risky short-term hold, esp. with its recent uptrend w/o news.